Research Options:

Week of Expected Pricing 10/6/2021
Company Name PHOENIX BIOTECH ACQUISITION CORP
Proposed Ticker PBAXU
CUSIP 71902K204
Business Description A newly organized blank check company incorporated as a Delaware corporation formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination or our business combination.
Lead Underwriter Cantor Fitzgerald & Co.
Co-Managers N/A
Initial Shares 1,55,00,000
Revised Initial Shares N/A
Initial Price $10.00-$10.00
Revised Price N/A
Final Price $10.00
Final Ticker PBAXU

 

 

   
  © 2024 ICE Data Services. All rights reserved.